cefazolin
Generic: cefazolin
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
cefazolin
Generic Name
cefazolin
Labeler
apotex corp.
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Routes
Active Ingredients
cefazolin sodium 3 g/1
Manufacturer
Identifiers & Regulatory
Product NDC
60505-6266
Product ID
60505-6266_10b501ca-c77f-4b3f-85df-ddf2715bfcd0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203661
Listing Expiration
2026-12-31
Marketing Start
2024-02-13
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605056266
Hyphenated Format
60505-6266
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cefazolin (source: ndc)
Generic Name
cefazolin (source: ndc)
Application Number
ANDA203661 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 3 g/1
Packaging
- 25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6266-5) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (60505-6266-0)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "10b501ca-c77f-4b3f-85df-ddf2715bfcd0", "openfda": {"upc": ["0360505623105", "0360505614202"], "unii": ["P380M0454Z"], "rxcui": ["1665050", "1665060", "2630753"], "spl_set_id": ["0422fe47-c372-494f-bac2-612f550b44a4"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6266-5) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (60505-6266-0)", "package_ndc": "60505-6266-5", "marketing_start_date": "20240213"}], "brand_name": "Cefazolin", "product_id": "60505-6266_10b501ca-c77f-4b3f-85df-ddf2715bfcd0", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "60505-6266", "generic_name": "Cefazolin", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cefazolin", "active_ingredients": [{"name": "CEFAZOLIN SODIUM", "strength": "3 g/1"}], "application_number": "ANDA203661", "marketing_category": "ANDA", "marketing_start_date": "20240213", "listing_expiration_date": "20261231"}